Search results
Found 2 matches for
A collaboration between the Russell group (Chemistry and Pharmacology) and the Davies group (Physiology, Anatomy and Genetics) has identified, via a chemical proteomics and phenotypic profiling strategy, the arylhydrocarbon receptor (AhR) as the molecular target of ezutromid, the utrophin modulator that recently completed a Phase 2 clinical trial in Duchenne muscular dystrophy patients.
Vasudevan lab explores key link between sleep pressure and circadian rhythms
Department Vasudevan Group
23 April 2021
Vasudevan lab identifies novel means of improving sensitivity and efficiency for PCR COVID testing
Department Vasudevan Group
9 April 2021
In collaboration with the infectious disease units at the John Radcliffe and Churchill Hospitals, the Vasudevan lab has identified a novel means of improving RT-qPCR sensitivity and efficiency for the detection of SARS-CoV-2 through the concentration of pooled patient lysates.